glp-1 and liver cirrhosis Therapies Reduce Risk of Cirrhosis, Complications of MASLD GLP-1s Gain Ground in Liver

Author contributions KPN: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing original draft, Writing review & editing

Discussion In this systematic review and meta-analysis we summarised and synthesised the most up-to-date data from RCTs of once-weekly tirzepatide in individuals with type 2 diabetes

The Clinical Evidence Gap Between Supplements and Prescription GLP-1s Prescription semaglutide demonstrated average weight loss of 9-15% in randomized controlled trials, with some patients losing more than 20% of body weight over one year

S.QuinnJ.ReddyP